These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 18678492

  • 1. Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase.
    Abouzid K, Shouman S.
    Bioorg Med Chem; 2008 Aug 15; 16(16):7543-51. PubMed ID: 18678492
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study.
    El-Azab AS, Al-Omar MA, Abdel-Aziz AA, Abdel-Aziz NI, el-Sayed MA, Aleisa AM, Sayed-Ahmed MM, Abdel-Hamide SG.
    Eur J Med Chem; 2010 Sep 15; 45(9):4188-98. PubMed ID: 20599299
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors.
    Liu LT, Yuan TT, Liu HH, Chen SF, Wu YT.
    Bioorg Med Chem Lett; 2007 Nov 15; 17(22):6373-7. PubMed ID: 17889528
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and biological evaluation of chrysin long-chain derivatives as potential anticancer agents.
    Lv PC, Wang KR, Li QS, Chen J, Sun J, Zhu HL.
    Bioorg Med Chem; 2010 Feb 15; 18(3):1117-23. PubMed ID: 20056425
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and antitumor evaluation of novel 5-substituted-4-hydroxy-8-nitroquinazolines as EGFR signaling-targeted inhibitors.
    Jin Y, Li HY, Lin LP, Tan J, Ding J, Luo X, Long YQ.
    Bioorg Med Chem; 2005 Oct 01; 13(19):5613-22. PubMed ID: 15993078
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activity.
    Li HQ, Li DD, Lu X, Xu YY, Zhu HL.
    Bioorg Med Chem; 2012 Jan 01; 20(1):317-23. PubMed ID: 22112541
    [Abstract] [Full Text] [Related]

  • 10. New substituted 4-arylaminoquinazolines as potent inhibitors of breast tumor cell lines: in vitro and docking experiments.
    de Oliveira AN, Bocca CC, Carvalho JE, Ruiz AL, Silva TP, Rittner R, Hoehr NF.
    Eur J Med Chem; 2010 Sep 01; 45(9):4339-42. PubMed ID: 20627376
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors.
    Lv PC, Zhou CF, Chen J, Liu PG, Wang KR, Mao WJ, Li HQ, Yang Y, Xiong J, Zhu HL.
    Bioorg Med Chem; 2010 Jan 01; 18(1):314-9. PubMed ID: 19914835
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and anti-proliferative activity of substituted-anilinoquinazolines and its relation to EGFR inhibition.
    El Ella DA, Saleh KA, Hassan M, Hamdy N, El-Araby ME, Abouzid KA.
    Arzneimittelforschung; 2012 Aug 01; 62(8):360-6. PubMed ID: 22723174
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, antitumor evaluation and docking study of novel 4-anilinoquinazoline derivatives as potential epidermal growth factor receptor (EGFR) inhibitors.
    Rao GW, Xu GJ, Wang J, Jiang XL, Li HB.
    ChemMedChem; 2013 Jun 01; 8(6):928-33. PubMed ID: 23640754
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Exploring epidermal growth factor receptor (EGFR) inhibitor features: the role of fused dioxygenated rings on the quinazoline scaffold.
    Chilin A, Conconi MT, Marzaro G, Guiotto A, Urbani L, Tonus F, Parnigotto P.
    J Med Chem; 2010 Feb 25; 53(4):1862-6. PubMed ID: 20095624
    [Abstract] [Full Text] [Related]

  • 20. Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer.
    Garofalo A, Goossens L, Lemoine A, Farce A, Arlot Y, Depreux P.
    J Enzyme Inhib Med Chem; 2010 Apr 25; 25(2):158-71. PubMed ID: 20222760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.